RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Studying Acute graft versus host disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alliance for Clinical Trials in Oncology
- Principal Investigator
- daniel_deangelo@dfci.harvard.edu J. DeAngelo, MD, PhDDana-Farber Cancer Institute
- Intervention
- Allopurinol(drug)
- Enrollment
- 310 enrolled
- Eligibility
- 18-39 years · All sexes
- Timeline
- 2017 – 2027
Study locations (30)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC, Anchorage, Alaska, United States
- Alaska Women's Cancer Care, Anchorage, Alaska, United States
- Anchorage Oncology Centre, Anchorage, Alaska, United States
- Katmai Oncology Group, Anchorage, Alaska, United States
- Providence Alaska Medical Center, Anchorage, Alaska, United States
- Fairbanks Memorial Hospital, Fairbanks, Alaska, United States
- Kingman Regional Medical Center, Kingman, Arizona, United States
- Mayo Clinic Hospital in Arizona, Phoenix, Arizona, United States
- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
- Mercy Hospital Fort Smith, Fort Smith, Arkansas, United States
- Kaiser Permanente-Deer Valley Medical Center, Antioch, California, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03150693 on ClinicalTrials.govOther trials for Acute graft versus host disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07295483Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)Instituto de Investigación Biomédica de Salamanca
- RECRUITINGPHASE3NCT07253181Tenecteplase Before Interhospital Transfer for EVT in Acute Anterior Circulation LVO at 4.5-24 HoursXuanwu Hospital, Beijing
- RECRUITINGNANCT07467694Postnatal Exercise to Activate Baby's Brown FatJoslin Diabetes Center
- RECRUITINGNCT07435805Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia EvaluationElazıg Fethi Sekin Sehir Hastanesi
- RECRUITINGPHASE2NCT07334379Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility StudyLorenzo delSorbo
- ENROLLING BY INVITATIONPHASE1, PHASE2NCT07163299Intra-arterial Selective Hypothermic Magnesium Sulfate Infusion in Combination With Endovascular Thrombectomy in Acute Ischemic StrokeCapital Medical University
- RECRUITINGNANCT06918964TaVNS for Acute Intracerebral HemorrhageBeijing Tiantan Hospital
- RECRUITINGNCT07548580Physical Mobilisation to Acquired Brain Injury Patients in Intensive Care Units: a Prospective Cohort StudyRigshospitalet, Denmark